Trial Details
COMPLETEDBasic Information
| Clinical ID | c3019 |
|---|---|
| Identifier | NCT02630966 |
| Trial Title | Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab|DRUG: Placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Nashville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2016-08-10 |
|---|---|
| Primary Completion Date | 2018-09-04 |
| Completion Date | 2018-11-14 |